Publication | Closed Access

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial

Surgical OncologyMedicinePrevious ChemotherapyPleural DiseasePlacebo-controlled TrialCancer TreatmentOncologyRadiation OncologyCancer ResearchPhase 3